Anticoagulation status of elderly patients with non-valvular atrial fibrillation in secondary and tertiary hospitals of Chongqing

Anticoagulation status of elderly patients with non-valvular atrial fibrillation in secondary and tertiary hospitals of Chongqing

Objective To investigate the current status of anticoagulation therapy for the elderly patients aged 75 years or over with non-valvular atrial fibrillation in secondary and tertiary hospitals in Chongqing. Methods A total of 3 821 patients aged 75 years old or over with non-valvular atrial fibrillat...

Full description

Bibliographic Details
Main Authors:	XIA Zhen, LU Kai, CHEN Xianya, XIE Siyuan, HU Huachao, XIAO Hua
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Third Military Medical University 2021-02-01
Series:	Di-san junyi daxue xuebao
Subjects:	aged non-valvular atrial fibrillation anticoagulation therapy new oral anticoagulants warfarin current situation investigation
Online Access:	https://aammt.tmmu.edu.cn/Upload/rhtml/202008168.htm

Similar Items

Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Yasmin de Souza Lima Bitar, et al.
Published: (2021-09-01)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
by: Joseph M. Harburger, et al.
Published: (2012-05-01)

Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
by: Masahiro Yasaka
Published: (2012-12-01)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01)

Usage of oral anticoagulant and influencing factors in nonvalvular atrial fibrillation: an analysis of 3 984 inpatients
by: XIANG Jing, et al.
Published: (2021-06-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
by: Jia Wu, et al.
Published: (2020-07-01)

Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
by: Antonio de Padua Mansur, et al.
Published: (2012-01-01)

Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population
by: Kiran Gupta, et al.
Published: (2019-06-01)

Outcomes and direct treatment costs with novel oral anticoagulants compared to clinic-monitored warfarin for stroke prevention in atrial fibrillation
by: Hulvershorn, Sarah Elizabeth
Published: (2014)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Anticoagulation in Patients with End-Stage Renal Disease and Non-Valvular Atrial Fibrillation – Review Article
by: Mahmoud Khalifa, et al.
Published: (2021-05-01)

Non-pharmacologic approach to prevent embolization in patients with atrial fibrillation in whom anticoagulation is contraindicated
by: Munish Sharma, et al.
Published: (2017-01-01)

Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)
by: Fawad Farooq, et al.
Published: (2017-12-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

Approaches to anticoagulation therapy selection in patients with non-valvular atrial fibrillation and ischemic heart disease
by: N. A. Koziolova, et al.
Published: (2016-04-01)

Anticoagulation control among patients with nonvalvular atrial fibrillation: A single tertiary cardiac center experience
by: Shaban Mohammed, et al.
Published: (2017-01-01)

Atrial fibrillation and stroke in the perspective of new oral anticoagulants
by: Demet Funda Baş, et al.
Published: (2013-02-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

Quality of anticoagulation control among patients with atrial fibrillation: An experience of a tertiary care center in Saudi Arabia
by: Sarah M. Alyousif, et al.
Published: (2016-10-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)

POSSIBILITY OF NOVEL ORAL ANTICOAGULANTS USAGE DURING ABLATION IN ATRIAL FIBRILLATION
by: B. A. Tatarsky, et al.
Published: (2014-12-01)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
by: Yuji Murakawa, MD, et al.
Published: (2017-06-01)

New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01)

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation
by: Daiki Shimomura, et al.
Published: (2015-08-01)

Treatment of very old patients with non valvular atrial fibrillation. The valuable opportunity offered by New Oral Anticoagulants, to be cautiously used
by: Francesco Orso, et al.
Published: (2013-12-01)

Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice
by: A. A. Zarudsky, et al.
Published: (2020-03-01)

Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences
by: Yoga Waranugraha, et al.
Published: (2021-08-01)

Comparison of Renal Function Estimation Formulae for Dosing Direct Oral Anticoagulants in Patients with Atrial Fibrillation
by: Kwang-No Lee, et al.
Published: (2019-11-01)

ANTICOAGULANT TREATMENT OF AF: FOCUS ON THE WARFARIN DOSAGE
by: Y. Kovbasniuk, et al.
Published: (2015-10-01)

Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation
by: Marco Bellone, et al.
Published: (2018-02-01)

The Prevalence of Prescription of New Anticoagulant Drugs and Its Determinant Factors in Patients With Ischemic Stroke and Non-valvular Atrial Fibrillation
by: Yaser Moaddabi, et al.
Published: (2020-03-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01)

Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword
by: Francesco Vetta, et al.
Published: (2017-07-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting
by: Gediminas Urbonas, et al.
Published: (2019-01-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
by: Inki Moon, et al.
Published: (2019-10-01)

Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01)